Evidence map›Paper›PMID 38766997›Full record

ReviewPediatric transplantation2024

Strategies for choosing the best living donor: A review of the literature and a proposal of a decision-making paradigm.

Olga Charnaya, Kyle Van Arendonk, Dorry L Segev

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Pediatric transplantation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Olga CharnayaDepartment of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.ORCID 0000-0003-1104-2882
Kyle Van ArendonkDepartment of Surgery, Nationwide Children's Hospital, Columbus, Ohio, USA.
Dorry L SegevC-STAR, NYU Langone, New York, New York, USA.

Funding

Patient Oriented Research in Kidney Disease and Transplant SurgeryK24DK101828 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SEGEV, DORRY L. · 2014 to 2018
$922k
Implementation of Eplet Mismatch Analysis in Pediatric Kidney TransplantationK08DK134762 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Olga Charnaya · 2023 to 2026
$697k
National Institute of Allergy and Infectious DiseasesNIDDK NIH HHS K08 DK134762NIDDK NIH HHS K08DK134762NIDDK NIH HHS K24 DK101828NIDDK NIH HHS K24DK101828
6 · The paper itself

Abstract

Transplantation remains the gold-standard treatment for pediatric end-stage kidney disease. While living donor transplant is the preferred option for most pediatric patients, it is not the right choice for all. For those who have the option to choose between deceased donor and living donor transplantation, or from among multiple potential living donors, the transplant clinician must weigh multiple dynamic factors to identify the most optimal donor. This review will cover the key considerations when choosing between potential living donors and will propose a decision-making algorithm.

Indexed as

Kidney Failure, ChronicKidney TransplantationLiving DonorsAlgorithmsChildClinical Decision-MakingDecision MakingDonor SelectionHumansdecision‐making paradigmliving donorpediatrictransplant

Identifiers

PMID38766997
PMCPMC11107570

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.